New Market Study, "Harbor MedTech, Inc. - Product Pipeline Analysis", Has Been Published
Harbor MedTech, Inc. (Harbor) develops and commercializes wound healing technology. Harbor has strategic partnership with Edwards Lifesciences, a xenograft-based device company, in which the company acquired the exclusive license of patented collagen stabilizing technology, BriDGE. Extensive studies carried out by Edwards and other independent researchers have shown that BriDGE processed xenografts support fast healing and an unprecedented degree of control over the softness, strength, and resorbability of its products. The company is commercializing a portfolio of products with its BriDGE...
View full press release